Life Sciences Newsletter, April 2017
Changes in guidelines on named patient programmesDicle Doğan and Merve Çimen, Gun + Partners On 29 March 2017, the Turkish Medicines and Medical Devices Agency amended the Guidelines on the Supply from Abroad and the Use of Pharmaceuticals. The amended guidelines establish a new practice in the Named Patient Programme (NPP) that enables the Social Security Institution to import non-approved or unavailable pharmaceutical products from abroad on a named patient basis. The…
Invest in Turkey Forum 2017
This event has passed. Gün + Partners is joining the 5th Invest in Turkey Forum 2017 in London on 28 April 2017. Ozan Karaduman, Managing Associate, is the panellist in “The Energy Industry in Turkey – The Most Important Questions?” session. Topics for discussion include: Turkish energy strategies: Where is Turkey headed? What projects are expected to be announced over the next 12 months? What changes are being made to regulatory / legislative framework to determine more…